Article Details
Retrieved on: 2024-09-13 17:58:25
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca PLC (AZN) announced on Friday that ENHERTU showed significant clinical effectiveness in patients with HER2-positive metastatic breast ...
Article found on: www.rttnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here